|
|
||||||||
AJP - Cell Physiology, Vol 256, Issue 2 C260-C264, Copyright © 1989 by American Physiological Society
ARTICLES |
G. P. Brown, G. K. Iwamoto, M. M. Monick and G. W. Hunninghake
Department of Internal Medicine, Veterans Administration, Iowa City, Iowa 52242.
To determine whether alveolar macrophages from smokers have an abnormal interleukin 1 beta (IL-1) release, we obtained macrophages by bronchoalveolar lavage (BAL) of otherwise healthy volunteers in three groups: nonsmokers (NS; n = 11), light smokers (LS, less than 10 pack-yr smoking history; n = 4) and heavy smokers (HS, greater than 10 pack-yr smoking history; n = 9). After 24 h in culture, unstimulated macrophages (from each group) released negligible amounts of IL-1. Lipopolysaccharide (LPS) (1 micrograms/ml) caused release of 21.77 +/- 4.33 ng IL-1/10(6) cells at 24 h from NS macrophages; IL-1 release from HS macrophages was significantly decreased (5.52 +/- 1.66 ng/10(6) cells; P less than 0.05), whereas LS macrophages released intermediate amounts (15.07 +/- 6.15 ng/10(6) cells). Release of IL-1 from HS macrophages was also decreased after 48 and 72 h in culture and was observed over a wide range of concentrations of LPS. The decreased amount of IL-1 in HS macrophage supernatants appeared to be due to a defect in release of IL-1 from the cells and not due to a defect in production of the mediator, since total IL-1 (IL-1 present in the cell lysates plus that in the cell supernatants) was similar in the NS and HS groups. In addition, after 24 h in culture, LPS-stimulated HS macrophages released significantly less prostaglandin E2 (PGE2) (which can suppress IL-1 production) than did NS macrophages; in the presence of indomethacin, which abolished macrophage PGE2 release, no augmentation of LPS-stimulated IL-1 release was observed. Cell viability, as measured by lactate dehydrogenase release, was not different between HS and NS macrophages under any conditions. We conclude that there is a defect in release but not production of IL-1 from the alveolar macrophages of chronic smokers.
This article has been cited by other articles:
![]() |
H. M. Wu, M. Jin, and C. B. Marsh Toward functional proteomics of alveolar macrophages Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L585 - L595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murin and J. Inciardi Cigarette Smoking and the Risk of Pulmonary Metastasis From Breast Cancer Chest, June 1, 2001; 119(6): 1635 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. WEWERS, P. T. DIAZ, M. E. WEWERS, M. P. LOWE, H. N. NAGARAJA, and T. L. CLANTON Cigarette Smoking in HIV Infection Induces a Suppressive Inflammatory Environment in the Lung Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1543 - 1549. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |